WHO validates Sinovac COVID-19 vaccine for emergency use and issues interim policy recommendations
World Health Organization (WHO) on Tuesday 1 June 2021 validated the Sinovac-CoronaVac COVID-19 vaccine for emergency use, giving countries, funders, procuring agencies and communities the assurance that it meets international standards for safety, efficacy and manufacturing. The vaccine is produced by the Beijing-based pharmaceutical company Sinovac. “The world desperately needs multiple COVID-19 vaccines to address…